| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
185,611,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
6,246,627 |
Avg
Vol: |
2,897,741 |
| 52
Week Range: |
$23.99 - $23.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Clackson Timothy P |
President, R&D, CSO |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$92,820 |
D/D |
(14,667) |
428,232 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
442,899 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs and HR |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$102,089 |
D/D |
(16,134) |
100,129 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs and HR |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
116,263 |
|
- |
|
| Berstein David L |
SVP, Chief IP Counsel |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$92,826 |
D/D |
(14,667) |
222,074 |
|
- |
|
| Berstein David L |
SVP, Chief IP Counsel |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
236,741 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,000 |
1,250,564 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$102,107 |
D/D |
(16,134) |
108,499 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
124,633 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$92,823 |
D/D |
(14,667) |
137,722 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
152,389 |
|
- |
|
| Riedel Norbert G |
Director |
• • – |
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
109,359 |
|
- |
|
| Radaelli Massimo |
Director |
• • – |
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
93,000 |
|
- |
|
| Schlesinger Sarah J. |
Director |
• • – |
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
25,000 |
|
- |
|
| Lavidas Athanese |
Director |
• • – |
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
119,131 |
|
- |
|
| Wilson Wayne |
Director |
• • – |
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
113,000 |
|
- |
|
| Denner Alexander J |
Director |
• • – |
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22,665 |
22,665 |
|
- |
|
| Lamarche Jay R |
Director |
• • – |
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
439,705 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2015-01-23 |
4 |
AB |
$6.18 |
$77,250 |
I/I |
12,500 |
1,839,286 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2015-01-22 |
4 |
AB |
$6.16 |
$76,990 |
I/I |
12,500 |
1,826,786 |
|
- |
|
| Schlesinger Sarah J. |
Director |
• • – |
2015-01-14 |
4 |
AB |
$6.25 |
$8,125 |
I/I |
1,300 |
15,600 |
|
- |
|
| Schlesinger Sarah J. |
Director |
• • – |
2015-01-13 |
4 |
AB |
$6.97 |
$9,061 |
I/I |
1,300 |
14,300 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2014-12-18 |
4 |
AB |
$6.54 |
$81,770 |
I/I |
12,500 |
1,814,286 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2014-12-17 |
4 |
AB |
$6.15 |
$76,875 |
I/I |
12,500 |
1,801,786 |
|
- |
|
| Schlesinger Sarah J. |
Director |
• • – |
2014-12-17 |
4 |
AB |
$6.11 |
$7,943 |
I/I |
1,300 |
13,000 |
|
- |
|
703 Records found
|
|
Page 7 of 29 |
|
|
